Professor of Pediatrics, Johns Hopkins University School of Medicine
| Role | Organisation | Sources |
|---|---|---|
| Associate Editor (former) | Journal of Allergy and Clinical Immunology | Brandon Capital portfolio |
| Associate Editor (former) | Annals of Allergy, Asthma, and Immunology | Brandon Capital portfolio |
| Chief of the Eudowood Division of Allergy and Immunology | Johns Hopkins Children's Center | Brandon Capital portfolio |
| Deputy Editor (former) | Pediatric Allergy and Immunology | Brandon Capital portfolio |
| Director of the Pediatric Allergy Clinics | The Johns Hopkins Hospital | Brandon Capital portfolio |
| Professor of International Health | Johns Hopkins Bloomberg School of Public Health | Brandon Capital portfolio |
| Professor of Pediatrics | Johns Hopkins University School of Medicine | Brandon Capital portfolio |
Stories naming Dr Robert A. Wood. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Aravax clears its US FDA application to trial its peanut-allergy immunotherapy PVX108 in Phase 2 studies across two countries, and adds a prominent food-allergy paediatric specialist to its scientific advisory board.